Skip to main content

Table 2 Effects of marital status on all-cause and cause-specific mortality (ICD-10 codes in parentheses) 2004-2007 a and the chance of purchasing various types of medicines for circulatory disorders 2004-2008 among women and men aged 50-79 b

From: Underuse of medication for circulatory disorders among unmarried women and men in Norway?

  

Effects of marital status (with 95% confidence intervals)

Number of deaths or persons purchasing the medicines

  

Never-married

Widowed

Divorced/separated

 

Men

Mortality from

All causes

2.05*** (1.98-2.11)

1.56*** (1.50-1.62)

1.96*** (1.91-2.02)

35174

 

All circulatory diseases (I00-I99)

2.11*** (1.99-2.23)

1.65*** (1.54-1.75)

2.08*** (1.97-2.18)

10880

 

Ischemic heart diseases (I20-I25)

1.94*** (1.80-2.10)

1.67*** (1.52-1.82)

1.93*** (1.80-2.07)

5737

 

Other heart diseases (I26-I52)

2.71*** (2.39-3.08)

1.63*** (1.52-1.82)

2.52*** (2.24-2.85)

1809

 

Cerebrovascular diseases (I60-I69)

1.99*** (1.75-2.26)

1.51*** (1.31-1.74)

2.07*** (1.84-2.33)

2066

 

Other circulatory diseases

2.13*** (1.81-2.50)

1.75*** (1.46-2.10)

2.11*** (1.82-2.10)

1268

Purchase of medication for

Coronary and peripheral vascular diseases, antiplateletc

0.70*** (0.68-0.73)

1.00 (0.95-1.05)

1.02 (0.99-1.05)

42780

 

Coronary and peripheral vascular diseases, anticoagulantd

0.88*** (0.85-0.91)

1.04* (1.00-1.08)

1.03** (1.00-1.06)

59898

 

Hypertensione

0.98 (0.95-1.01)

1.10*** (1.06-1.15)

0.97*** (0.94-0.99)

56019

 

Hyperlipedemiaf

0.69*** (0.68-0.71)

0.95*** (0.93-0.98)

0.89*** (0.87-0.90)

185023

 

Anti-arrhythmic cardiac diseasesg

1.02 (0.97-1.08)

1.09*** (1.03-1.16)

1.09*** (1.04-1.14)

18204

 

Ischemic heart diseases/anginah

0.75*** (0.73-0.78)

0.98 (0.94-1.02)

0.99 (0.97-1.02)

65918

 

Congestive heart failure/hypertensioni

0.92*** (0.90-0.94)

1.10*** (1.07-1.32)

0.96*** (0.95-0.98)

195657

 

Other ischemic heart diseases/hypertensionj

0.88*** (0.86-0.90)

1.08*** (1.05-1.11)

0.96*** (0.94-0.97)

198133

Women

     

Mortality from

All causes

2.05*** (1.95-2.15)

1.40*** (1.35-1.44)

1.70*** (1.64-1.77)

23970

 

All circulatory diseases (I00-I99)

2.37*** (2.15-2.61)

1.53*** (1.44-1.62)

1.83*** (1.69-1.98)

5848

 

Ischemic heart diseases (I20-I25)

2.38*** (2.05-2.77)

1.44*** (1.31-1.59)

1.80*** (1.59-2.04)

2323

 

Other heart diseases (I26-I52)

2.84*** (2.30-3.50)

1.66*** (1.44-1.90)

2.14*** (1.79-2.56)

1163

 

Cerebrovascular diseases (I60-I69)

2.18*** (1.82-2.61)

1.51*** (1.35-1.69)

1.63*** (1.40-1.91)

1678

 

Other circulatory diseases

1.94*** (1.43-2.64)

1.63*** (1.36-1.95)

1.91*** (1.36-1.95)

684

Purchase of medication for

Coronary and peripheral vascular diseases, antiplatelet c

0.84*** (0.78-0.90)

1.12*** (1.08-1.16)

1.24*** (1.19-1.29)

22058

 

Coronary and peripheral vascular diseases, anticoagulantd

0.92*** (0.88-0.96)

1.07*** (1.04-1.10)

1.08*** (1.05-1.11)

51264

 

Hypertensione

0.96* (0.93-1.00)

1.03*** (1.01-1.06)

0.94*** (0.92-0.97)

58882

 

Hyperlipedemiaf

0.78*** (0.77-0.81)

0.95*** (0.94-0.97)

0.92*** (0.91-0.94)

175477

 

Anti-arrhythmic cardiac diseasesg

1.00 (0.92-1.09)

1.08*** (1.03-1.13)

1.07** (1.01-1.14)

11746

 

Ischemic heart diseases/anginah

0.85*** (0.82-0.89)

1.11*** (1.08-1.13)

1.20*** (1.16-1.23)

52641

 

Congestive heart failure/hypertensioni

0.95*** (0.93-0.97)

1.07*** (1.06-1.09)

0.99 (0.97-1.01)

203305

 

Other ischemic heart diseases/hypertensionj

0.87*** (0.85-0.89)

1.03*** (1.01-1.04)

0.94*** (0.92-0.95)

187899

  1. aDiscrete-time hazard models are estimated. The models also include age (in five-year groups), year (in one-year groups), and educational level (in five categories). *p < 0.10; **p < 0.05; ***p < 0.01.
  2. bLogistic models for the chance of purchasing the medicines are estimated. The models also include age (in five-year groups) and educational level (in five categories). Medicines are grouped as in Kuo et al. [41]. See details in notes c-j.
  3. cATC codes B01AC, C04AD03 (except B01AC06, B01AC08, B01AC09, B01AC11, B01AC15, B01AC19, B01AC21).
  4. dATC codes B01AA, B01AB, B01AD, B01AX.
  5. eATC codes C02AA02, C02AB02, C02AC, C02BA, C02BB, C02CA, C02CC, C02DA, C02DB, C02DD, C02DG, C03AA, C03AB, C03AX, C03DA, C03DB, C02L.
  6. fATC codes C10AA, C10AB, C10AC, C10AD, C10AX, C10BA, C10BX.
  7. gATC codes C01AA, C01BA, C01BB, C01BC, C01BD, C01BG, C01EB10.
  8. hATC codes C01DA, C01DX16.
  9. iATC codes C01CA07, C01CE01, C01CE02, C01EB09, C03CA, C03CB, C03CC, C09AA, C09BA, C09BB, C09CA, C09DA, C09DB.
  10. jATC codes C07AA, C07AB, C07AG, C07BA, C07BB, C07BG, C07CA, C07CB, C07CG, C07DA, C07DB, C07EA, C07EB, C07FA, C07FB, C08CA, C08CX, C08DA, C08DB, C08EA, C08EX, C08GA.
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us